Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: MAYO CLINIC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-08-01 to 2023-03-31
Current total value of award: $748353.67
Description: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MERIVA (R) AS A CANDIDATE CHEMOPREVENTION AGENT FOR GASTRIC CARCINOGENESIS